AMPX is caught in a genuine tug-of-war: the stock just posted its biggest weekly gain in months, a new analyst fired the opening shot with a bullish initiation, and the people running the company quietly sold into every uptick.
The stock closed at $22.91 on Tuesday, up 28.5% on the week and 5.3% on the day alone. That kind of move in a single week commands attention — but the context matters as much as the number. The rally came on the back of Clear Street initiating coverage on June 3 with a Buy rating and a $33 price target, a level roughly 44% above where the stock closed. That is the most bullish formal target on record for Amprius and sits well above the existing analyst consensus of $22.13. It shifts the Street's centre of gravity.
The bulls have a coherent case. Amprius shipped product to 93 customers in the latest quarter, 43 of them new. Operating losses narrowed sharply, from $12.9 million to $6.8 million sequentially. Management projects gross margins expanding from roughly 15% today to 25-27% by 2028, with long-term revenue targets revised upward to $3.2 billion by 2036. The existing analyst roster — Needham, B. Riley, Craig-Hallum, Cantor Fitzgerald, Roth Capital — all hold Buy or Overweight ratings, with a wave of target-price upgrades that swept through in early March after the last earnings release. The bears counter with the basics: Amprius is still posting a net loss of roughly $6 million per quarter, and the path from early-stage niche supplier to billion-dollar manufacturer involves a lot of execution risk. The ORTEX EPS momentum factor scores make this tension explicit — 30-day EPS momentum ranks in the 95th percentile, while 90-day EPS momentum sits in the 1st. The near-term beat is real; the longer arc is far less certain.
The insider tape tells a cautious story. In the three weeks between May 21 and May 27, the CEO sold nearly 65,000 shares across two tranches for combined proceeds approaching $975,000. The CTO sold over 32,000 shares in the same window. Director Kang Sun — the most active seller on the register — added another 68,000 shares to a transaction trail that already includes over 1.5 million shares sold in early April. Chairman Donald Dixon sold a further 17,895 shares on May 26. None of these are forced or liquidation-scale events individually, but the coordination across C-suite and board in a two-week window, while the stock was rising, is worth noting. The net insider activity across the 90-day window runs to over 2.6 million shares sold, with a cumulative dollar value north of $44 million.
Short positioning adds another layer. At 17.7% of float, short interest is elevated and has been building steadily since late April — up roughly 6% over the past month. The SI level is high enough to matter, yet the borrow market shows no signs of stress: the cost to borrow runs at just 0.46% annualised, among the lowest readings of the past six weeks. Availability is loose at 258% of estimated short interest, well above the year's tightest reading of 75%. That combination — high SI, cheap borrow, plenty of supply — suggests bears are comfortable in their positions and under no pressure to cover. The short score of 60.8 is elevated but has actually eased slightly from a peak near 62.5 earlier in the week, a modest shift consistent with the rally rather than a signal of aggressive new shorting. Options sentiment, meanwhile, is close to neutral: the put/call ratio of 0.64 is fractionally below its 20-day average of 0.65, with no meaningful skew in either direction.
The next scheduled event is an earnings release on June 11. The prior print was a rough one — the stock fell nearly 25% on the day after Q4 results in early May, extending to an 19.5% decline over the following five days. That outcome followed a quarter where losses were already narrowing, which illustrates how sharply the stock can react when guidance or revenue trajectory disappoints. With the stock now trading at a 45% premium to where it stood on May 7, the bar for the June print is higher than it was then. The key question heading into that release is whether Q1 revenue momentum and customer additions confirm the trajectory the bulls — and now Clear Street — are pricing in, or whether the gap between the current price and the consensus target narrows for the wrong reasons.
See the live data behind this article on ORTEX.
Open AMPX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
